Literature DB >> 20440545

The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors.

Julianne M O'Daniel1.   

Abstract

One of the major anticipated benefits of genomic medicine is the area of preventive medicine. Commercially available genomic profiling is now able to generate risk information for a number of common conditions several of which have recognized preventive guidelines. Similarly, family history assessment affords powerful health risk prediction based on the shared genetic, physical and lifestyle environments within families. Thus, with the ability to help predict disease risk and enable preemptive health plans, genome-guided preventive medicine has the potential to improve population health on an individualized level. To realize this potential, steps to broaden access to accurate genomic health information must be considered. With expertise in genetic science, risk assessment and communication, and a patient-centered practice approach, genetic counselors are poised to play a critical role in facilitating the incorporation of genomic health risks into the burgeoning field of genome-guided preventive medicine.

Entities:  

Mesh:

Year:  2010        PMID: 20440545     DOI: 10.1007/s10897-010-9302-4

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  124 in total

1.  Genetic testing for disease susceptibilities: consequences for genetic counseling.

Authors:  Roberta A Pagon
Journal:  Trends Mol Med       Date:  2002-06       Impact factor: 11.951

Review 2.  Genetic evaluation for coronary artery disease.

Authors:  Maren T Scheuner
Journal:  Genet Med       Date:  2003 Jul-Aug       Impact factor: 8.822

3.  Guidelines for the diagnosis and management of Marfan syndrome.

Authors:  Lesley Ades
Journal:  Heart Lung Circ       Date:  2006-12-26       Impact factor: 2.975

Review 4.  A model for the development of genetics education programs for health professionals.

Authors:  Clara L Gaff; MaryAnne Aitken; Anna Flouris; Sylvia A Metcalfe
Journal:  Genet Med       Date:  2007-07       Impact factor: 8.822

5.  Personal genomes: The case of the missing heritability.

Authors:  Brendan Maher
Journal:  Nature       Date:  2008-11-06       Impact factor: 49.962

6.  Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.

Authors:  Saskia C Sanderson; Suzanne C O'Neill; Della Brown White; Gerold Bepler; Lori Bastian; Isaac M Lipkus; Colleen M McBride
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

7.  Personalized medicine in the era of genomics.

Authors:  Wylie Burke; Bruce M Psaty
Journal:  JAMA       Date:  2007-10-10       Impact factor: 56.272

8.  Interviews with primary care physicians regarding taking and interpreting the cancer family history.

Authors:  Marie E Wood; Alan Stockdale; Brian S Flynn
Journal:  Fam Pract       Date:  2008-09-01       Impact factor: 2.267

9.  Factors influencing uptake of pharmacogenetic testing in a diverse patient population.

Authors:  J O'Daniel; J Lucas; P Deverka; D Ermentrout; G Silvey; D F Lobach; S B Haga
Journal:  Public Health Genomics       Date:  2009-05-04       Impact factor: 2.000

10.  Needs assessment study of genetics education for general practitioners in Australia.

Authors:  Sylvia Metcalfe; Rosalind Hurworth; Jennifer Newstead; Rosemary Robins
Journal:  Genet Med       Date:  2002 Mar-Apr       Impact factor: 8.822

View more
  34 in total

1.  Delivering a pharmacogenetic service: is there a role for genetic counselors?

Authors:  Alice Callard; William Newman; Katherine Payne
Journal:  J Genet Couns       Date:  2011-11-04       Impact factor: 2.537

2.  Commentary on genome-guided preventive medicine-new roles for genetic counselors.

Authors:  Elizabeth Gettig
Journal:  J Genet Couns       Date:  2010-06-19       Impact factor: 2.537

3.  Direct-to-consumer personal genomic testing: a case study and practical recommendations for “genomic counseling”.

Authors:  Amy C Sturm; Kandamurugu Manickam
Journal:  J Genet Couns       Date:  2012-06       Impact factor: 2.537

4.  Genetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders.

Authors:  Jessica L Waxler; Kelsey E O'Brien; Linda M Delahanty; James B Meigs; Jose C Florez; Elyse R Park; Barbara R Pober; Richard W Grant
Journal:  J Genet Couns       Date:  2012-10       Impact factor: 2.537

5.  Genomic counseling: next generation counseling.

Authors:  Rachel Mills; Susanne B Haga
Journal:  J Genet Couns       Date:  2013-09-12       Impact factor: 2.537

6.  Assessing the integration of genomic medicine in genetic counseling training programs.

Authors:  Jessica Profato; Erynn S Gordon; Shannan Dixon; Andrea Kwan
Journal:  J Genet Couns       Date:  2014-01-08       Impact factor: 2.537

7.  Implementation of a clinical research pharmacogenomics program at an academic medical center: role of the genetics healthcare professional.

Authors:  Amy Curry Sturm; Kevin Sweet; Kandamurugu Manickam
Journal:  Pharmacogenomics       Date:  2013-05       Impact factor: 2.533

8.  Risk for Patient Harm in Canadian Genetic Counseling Practice: It's Time to Consider Regulation.

Authors:  Andrea L Shugar; Nada Quercia; Christopher Trevors; Marina M Rabideau; Sohnee Ahmed
Journal:  J Genet Couns       Date:  2016-06-07       Impact factor: 2.537

9.  Are Australasian Genetic Counselors Interested in Private Practice at the Primary Care Level of Health Service?

Authors:  Vrunda Sane; Linda Humphreys; Madelyn Peterson
Journal:  J Genet Couns       Date:  2015-01-21       Impact factor: 2.537

10.  Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research Study.

Authors:  Kevin Sweet; Shelly Hovick; Amy C Sturm; Tara Schmidlen; Erynn Gordon; Barbara Bernhardt; Lisa Wawak; Karen Wernke; Joseph McElroy; Laura Scheinfeldt; Amanda E Toland; J S Roberts; Michael Christman
Journal:  J Genet Couns       Date:  2016-12-05       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.